Результаты поиска - Jong Bok Lee

  • Отображение 1 - 7 результаты of 7
Отмена результатов
  1. 1
    Targeting chemotherapy-resistant leukemia by combining DNT cellular therapy with conventional chemotherapy

    Targeting chemotherapy-resistant leukemia by combining DNT cellular therapy with conventional chemotherapy по Branson Chen, Jong Bok Lee, Hyeonjeong Kang, Mark D. Minden, Zhang Li

    Опубликовано 2018
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  2. 2
    Developing Allogeneic Double-Negative T Cells as a Novel Off-the-Shelf Adoptive Cellular Therapy for Cancer

    Developing Allogeneic Double-Negative T Cells as a Novel Off-the-Shelf Adoptive Cellular Therapy for Cancer по Jong Bok Lee, Hyeonjeong Kang, Linan Fang, Cheryl D’Souza, Oyedele Adeyi, Zhang Li

    Опубликовано 2019
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  3. 3
    Mitochondrial and Metabolic Pathways Regulate Nuclear Gene Expression to Control Differentiation, Stem Cell Function, and Immune Response in Leukemia

    Mitochondrial and Metabolic Pathways Regulate Nuclear Gene Expression to Control Differentiation, Stem Cell Function, and Immune Response in Leukemia по Grace Egan, Dilshad H. Khan, Jong Bok Lee, Sara Mirali, Li Zhang, Aaron D. Schimmer

    Опубликовано 2021
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  4. 4
    Targeting late-stage non-small cell lung cancer with a combination of DNT cellular therapy and PD-1 checkpoint blockade

    Targeting late-stage non-small cell lung cancer with a combination of DNT cellular therapy and PD-1 checkpoint blockade по Linan Fang, Dalam Ly, Sisi Wang, Jong Bok Lee, Hyeonjeong Kang, Hao Xu, Junlin Yao, Ming‐Sound Tsao, Wei Liu, Zhang Li

    Опубликовано 2019
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  5. 5
    Human double negative T cells target lung cancer via ligand-dependent mechanisms that can be enhanced by IL-15

    Human double negative T cells target lung cancer via ligand-dependent mechanisms that can be enhanced by IL-15 по Junlin Yao, Dalam Ly, Dzana Dervovic, Linan Fang, Jong Bok Lee, Hyeonjeong Kang, Yuhui Wang, Nhu‐An Pham, Hongming Pan, Ming‐Sound Tsao, Li Zhang

    Опубликовано 2019
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  6. 6
    Allogeneic Human Double Negative T Cells as a Novel Immunotherapy for Acute Myeloid Leukemia and Its Underlying Mechanisms

    Allogeneic Human Double Negative T Cells as a Novel Immunotherapy for Acute Myeloid Leukemia and Its Underlying Mechanisms по Jong Bok Lee, Mark D. Minden, Weihsu C. Chen, Elena Streck, Branson Chen, Hyeonjeong Kang, Andrea Arruda, Dalam Ly, Sandy D. Der, Sohyeong Kang, Paulina Achita, Cheryl D’Souza, Yueyang Li, Richard W. Childs, John E. Dick, Li Zhang

    Опубликовано 2017
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  7. 7
    Venetoclax enhances T cell–mediated antileukemic activity by increasing ROS production

    Venetoclax enhances T cell–mediated antileukemic activity by increasing ROS production по Jong Bok Lee, Dilshad H. Khan, Rose Hurren, Mingjing Xu, Yoosu Na, Hyeonjeong Kang, Sara Mirali, Xiaoming Wang, Marcela Gronda, Yulia Jitkova, Neil MacLean, Andrea Arruda, Zoe Alaniz, Marina Konopleva, Michael Andreeff, Mark D. Minden, Zhang Li, Aaron D. Schimmer

    Опубликовано 2021
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:

Инструменты поиска: